feed,title,long_url,short_url
Benzinga,Enlivex Doses First Patient in Phase I/II Trial to Evaluate Allocetraâ„¢ for Advanced Solid Tumor Treatment,https://benzinga.com/general/biotech/22/11/29728559/enlivex-doses-first-patient-in-phase-iii-trial-to-evaluate-allocetra-for-advanced-solid-tumor-tre,https://bit.ly/3hNEeRS
Benzinga,"Hutchmed Plans Strategic Focus Shift On Late-Stage Programs, Details Not Disclosed",https://benzinga.com/general/biotech/22/11/29725032/hutchmed-plans-strategic-focus-shift-on-late-stage-programs-details-not-disclosed,https://bit.ly/3X6SGUU
